DRUG · Mapped RxNorm record
Adalimumab
Normalized identity: adalimumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
NCT06996652
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAn Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
AdalimumabDRUG · verified · RxNorm: adalimumab
PlaceboDRUG
Sponsors & collaborators
Yale Universitylead sponsor
The Marcus Foundationcollaborator
National Institute on Aging (NIA)collaborator
The Parkinson Study Groupcollaborator
Mapped research locations
BostonMassachusetts, United States2New YorkNew York, United States1HoustonTexas, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San AntonioTexas, United States1PortlandOregon, United States1MontrealQuebec, Canada1MinneapolisMinnesota, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06996652 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.